| Product Code: ETC328681 | Publication Date: Aug 2022 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant shift in its hydroxychloroquine and chloroquine import sources in 2024, with top exporters including Israel, Belgium, Japan, Sweden, and Denmark. The Herfindahl-Hirschman Index (HHI) indicated low concentration levels, showcasing a diversified import market. However, the compound annual growth rate (CAGR) from 2020 to 2024 was -21.67%, reflecting a declining trend in imports. Additionally, the growth rate from 2023 to 2024 plummeted by -59.13%, highlighting a steep decline in the import volume of these pharmaceutical products in the US market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Hydroxychloroquine And Chloroquine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Hydroxychloroquine And Chloroquine Market - Industry Life Cycle |
3.4 United States (US) Hydroxychloroquine And Chloroquine Market - Porter's Five Forces |
3.5 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
3.6 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United States (US) Hydroxychloroquine And Chloroquine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases and malaria in the United States |
4.2.2 Growing off-label use of hydroxychloroquine and chloroquine for COVID-19 treatment |
4.2.3 Favorable regulatory environment supporting the use of these drugs for various indications |
4.3 Market Restraints |
4.3.1 Safety concerns and side effects associated with hydroxychloroquine and chloroquine |
4.3.2 Discontinuation of clinical trials evaluating the efficacy of hydroxychloroquine for COVID-19 treatment |
5 United States (US) Hydroxychloroquine And Chloroquine Market Trends |
6 United States (US) Hydroxychloroquine And Chloroquine Market, By Types |
6.1 United States (US) Hydroxychloroquine And Chloroquine Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Dosage, 2022 - 2032F |
6.1.3 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 100 mg, 2022 - 2032F |
6.1.4 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 200 mg, 2022 - 2032F |
6.1.5 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 250 mg, 2022 - 2032F |
6.1.6 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 500 mg, 2022 - 2032F |
6.2 United States (US) Hydroxychloroquine And Chloroquine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By COVID-19, 2022 - 2032F |
6.2.3 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Rheumatoid Arthritis, 2022 - 2032F |
6.2.4 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Malaria, 2022 - 2032F |
6.2.5 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 United States (US) Hydroxychloroquine And Chloroquine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.3.3 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 United States (US) Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 United States (US) Hydroxychloroquine And Chloroquine Market Import-Export Trade Statistics |
7.1 United States (US) Hydroxychloroquine And Chloroquine Market Export to Major Countries |
7.2 United States (US) Hydroxychloroquine And Chloroquine Market Imports from Major Countries |
8 United States (US) Hydroxychloroquine And Chloroquine Market Key Performance Indicators |
8.1 Number of prescriptions for hydroxychloroquine and chloroquine |
8.2 Number of clinical trials investigating new indications for these drugs |
8.3 Patient adherence rates to hydroxychloroquine and chloroquine prescriptions |
8.4 Average length of treatment with hydroxychloroquine and chloroquine |
8.5 Patient satisfaction and reported outcomes with hydroxychloroquine and chloroquine treatment |
9 United States (US) Hydroxychloroquine And Chloroquine Market - Opportunity Assessment |
9.1 United States (US) Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Dosage, 2022 & 2032F |
9.2 United States (US) Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United States (US) Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United States (US) Hydroxychloroquine And Chloroquine Market - Competitive Landscape |
10.1 United States (US) Hydroxychloroquine And Chloroquine Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Hydroxychloroquine And Chloroquine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here